NKTR Stock Analysis: Buy, Sell, or Hold?
NKTR - Nektar Therapeutics
$37.33
2.10 (5.96%)
▲
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Mar 11, 2026
Get Alerted When NKTR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called NKTR this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: NKTR shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: NKTR shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: NKTR is currently trading at $37.33, which is considered slightly low relative to its 30-day fair value range of $36.23 to $42.64.
Technical Outlook: Technically, NKTR is in a strong uptrend. Immediate support is located at $33.40, while resistance sits at $39.75. The stock is showing strong short-term momentum, up 6.0% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $114.43 (+206.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NKTR is in a strong uptrend. Immediate support is located at $33.40, while resistance sits at $39.75. The stock is showing strong short-term momentum, up 6.0% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $114.43 (+206.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$36.23 -
$42.64
Company Quality Score
52/100
(HOLD)
Options IV Signal
67th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
84.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 67th percentile)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.0%)
- BULLISH: Trading 206.5% below Wall St target ($114.43)
Fair Price Analysis
30-Day Fair Range
$36.23 -
$42.64
Current vs Fair Value
SLIGHTLY LOW
Expected Move (7 Days)
±$6.11
(16.4%)
Support & Resistance Levels
Support Level
$33.40
Resistance Level
$39.75
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-3.15
Wall Street Target
$114.43
(+206.5%)
Revenue Growth (YoY)
-51.1%
Profit Margin
-192.9%
Last updated: February 01, 2026 4:50 AM ET
Data refreshes hourly during market hours. Next update: 5:50 AM
Data refreshes hourly during market hours. Next update: 5:50 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NKTR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Howard W Robin
SELL
6666 shares
2025-09-09
Howard W Robin
SELL
6666 shares
2025-09-05
Howard W Robin
SELL
5166 shares
2025-09-04
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 59 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 46 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$117 | 59 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$141 | 59 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 56 HOLD |
Advanced NKTR Option Strategies
Professional options setups generated by AI based on today's NKTR price and gamma walls.
